Indacaterol: the first once-daily long-acting beta2 agonist for copd
Éditeur :
Springer Basel
ISBN :
9783034807081
Date de publication :
27 nov. 2013
Dimensions :
23,5 x 15,5 cm
Langue :
Anglais
Pays d'origine :
Suisse
Here is a comprehensive overview of the development of Onbrez Breezhaler, a newly approved once-daily inhaled beta2 agonist for treating COPD. Covers design and pre-clinical pharmacology of the molecule, early clinical development, efficacy studies and more.